Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Scientists at University of Oviedo publish research in cancer gene therapy
October 21st, 2008
Data detailed in 'The TP53 Arg72Pro polymorphism and lung cancer risk in a population of Northern Spain' have been presented. "Polymorphisms in tumor suppressor genes might contribute to the individual susceptibility to develop different types of cancer. Alterations in genes involved in cell cycle regulation and apoptosis, as tumor suppressor gene TP53, can lead to malignant transformations increasing the risk of developing cancer," scientists in Oviedo, Spain report. The researchers concluded: "Polymorphisms in tumor suppressor genes might contribute to the individual susceptibility to develop different types of cancer. Alterations in genes involved in cell cycle...
Source: Cancer Weekly (2008-10-21)
|
